🔗 Share this article

Chancellor Reeves has announced she is preparing "focused measures to deal with household expense challenges" in the upcoming Budget.

Speaking to the BBC, she noted that curbing inflation is a shared task of both the administration and the central bank.

The United Kingdom's price growth is expected to be the highest among the G7 advanced economies this calendar year and next.

Possible Energy Bill Interventions

It is understood the administration could intervene to lower utility costs, such as by slashing the current 5% rate of VAT charged on energy.

A further possibility is to lower some of the policy costs presently included in household expenses.

Budgetary Constraints and Expert Predictions

The government will obtain the next report from the official forecaster, the OBR, on the start of the week, which will show how much space there is for such measures.

The consensus from most experts is that the Chancellor will have to introduce higher taxes or expenditure reductions in order to fulfill her declared debt limits.

Earlier on Thursday, estimates suggested there was a £22 billion gap for the chancellor to fill, which is at the lower end of expectations.

"It is a shared task between the central bank and the government to continue tackling some of the sources of inflation," Reeves informed the BBC in the US capital, at the yearly gatherings of the IMF and global financial institution.

Revenue Pledges and International Concerns

While much of the focus has been on expected tax rises, the chancellor said the most recent data from the OBR had not changed her vow to manifesto promises not to increase rates on income tax, VAT or National Insurance.

She attributed an "unpredictable world" with increasing international and commercial tensions for the Budget revenue measures, probably to be focused on those "wealthiest."

International Trade Disputes

Commenting on worries about the United Kingdom's economic relations with China she said: "Our security interests invariably take priority."

Last week's announcement by China to strengthen trade restrictions on rare earths and other resources that are essential for high-technology production led US President Donald Trump to propose an extra 100% import tax on imports from China, raising the prospect of an full-scale commercial conflict between the two largest economies.

The American finance chief called China's action "economic coercion" and "a global supply chain power grab."

Inquired about accepting the US offer to join its conflict with China, Reeves said she was "deeply worried" by China's actions and urged the Beijing authorities "not to put up barriers and limit trade."

She said the move was "damaging for the world economy and causes additional headwinds."

"In my view there are areas where we should address China, but there are also valuable chances to sell into China's economy, including banking sector and other areas of the economic system. We've got to get that equilibrium appropriate."

The Treasury chief also stated she was cooperating with G7 counterparts "on our own critical minerals strategy, so that we are more independent."

NHS Drug Costs and Investment

Reeves also recognized that the price the NHS spends on medicines could increase as a consequence of ongoing discussions with the Trump administration and its drugs companies, in exchange for lower tariffs and funding.

A number of the world's largest pharmaceutical manufacturers have said recently that they are either halting or abandoning operations in the United Kingdom, with some blaming the modest returns they are getting.

Last month, the government science advisor said the price the NHS spends on drugs would must rise to halt businesses and pharmaceutical investment leaving the UK.

The Chancellor stated to media: "It has been observed as a result of the cost structure, that clinical trials, new drugs have not been offered in the United Kingdom in the way that they are in other European countries."

"We want to ensure that people getting treatment from the NHS are can access the top essential drugs in the world. And so we are reviewing this situation, and... looking to secure more investment into the UK."